Lessons learned from the first wave of aging with HIV

AIDS

Volumn 26, Issue SUPPL.1, 2012, Pages

  Justice, Amy C ^a   Braithwaite, R Scott ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aging; comorbidity; HIV; polypharmacy; sociodemographics

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; GABAPENTIN; STAVUDINE; VIRUS RNA;

AFRICA; AGING; ANTIVIRAL THERAPY; ARTICLE; COGNITIVE DEFECT; ERECTILE DYSFUNCTION; EUROPE; HEALTH CARE COST; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; NORTH AMERICA; PERIPHERAL NEUROPATHY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; VIRUS INHIBITION; VIRUS LOAD; WEAKNESS;

AGING; COMORBIDITY; HEALTH SERVICES NEEDS AND DEMAND; HIV SEROPOSITIVITY; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; POLYPHARMACY; UNITED STATES;

EID: 84863838413     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283558500     Document Type: Article

References (84)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2007. Vol. 19. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. pp. 1-63. http://www.cdc.gov/hiv/ topics/surveil lance/resources/reports/.
2. Green TC, Kershaw T, Lin H, Heimer R, Goulet JL, Kraemer KL, et al. Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend 2010; 110:208-220.
3. Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007; 45:1593-1601. (Pubitemid 351411845)
4. Negin J, Mills EJ, Albone R. Continued neglect of ageing of HIV epidemic at UN meeting. Lancet 2011; 378:768.
5. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ 2010; 88:847-853.
6. Shaffer DN, Njeri R, Justice AC, Odero WW, Tierney WM. Alcohol abuse among patients with and without HIV infection attending public clinics in western Kenya. East Afr Med J 2004; 81:594-598. (Pubitemid 44138942)
7. Papas RK, Sidle JE, Martino S, Baliddawa JB, Songole R, Omolo OE, et al. Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav 2010; 14:669-678.
8. Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, Peduzzi PN. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc 2011; 59:2196.
9. Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc 2008; 56:1409-1416.
10. Park LS, Tate JP, Justice AC, Lo RV III, Lim JK, Brau N, et al. FIB-4 index is associated with hepatocellular carcinoma risk in HIVinfected patients. Cancer Epidemiol Biomarkers Prev 2011; 20:2512-2517.
11. Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis 2011; 53:1256-1264.
12. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-1139.
13. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006; 29:725-731. (Pubitemid 44115387)
14. Tinetti ME, Fried T. The end of the disease era. Am J Med 2004; 116:179-185. (Pubitemid 38121675)
15. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009; 338:a3172.
16. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009; 17:118-123.
17. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010; 7:69-76.
18. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22:2409-2418.
19. Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B, et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 2011; 6:e17217.
20. Freiberg MS, McGinnis K, Butt AA, Goetz M, Brown S, Oursler KA, et al., and the Veterans Aging Cohort Study and the VA HD Quality Enhancement Research Initiative. HIV is associated with clinically confirmed myocardial infarction after adjustment for smoking and other risk factors [abstract]. In: Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections; 2011; Boston.
21. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010; 153:452-460.
22. Sico J, Chang C, Freiberg M, Hylek E, Butt A, Gibert C, et al., The VACS Project Team. HIV infection and the risk of ischemic stroke in the VACS VC [abstract]. In: SGIM Minneapolis Poster; 2010.
23. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130:1326-1333. (Pubitemid 44786723)
24. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS 2005; 19 (Suppl 3):S99-S105. (Pubitemid 41682176)
25. Silverberg M, Lau B, D'Souza G, Engels E, Gill J, Goedert J, et al., for the North American AIDS Cohort Collaboration of Research and Design. Trends in cumulative incidence of cancer among HIV-infected patients in North America [abstract]. In: Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco.
26. Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr 2007; 44:463-469. (Pubitemid 46555383)
27. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenzcontaining antiretroviral therapy: role of hepatitis C and B infections. Hepatology 2002; 35:182-189. (Pubitemid 34032559)
28. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138:197-207. (Pubitemid 36231625)
29. Sliwa K, Stewart S, Gersh BJ. Hypertension: a global perspective. Circulation 2011; 123:2892-2896.
30. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology-summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006; 54:991-1001. (Pubitemid 43847040)
31. Kuller LH, Tracy R, Belloso W, De WS, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
32. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La RA, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795.
33. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010; 121:651-658.
34. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59:255-263. (Pubitemid 38375339)
35. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687-699. (Pubitemid 38586809)
36. Kuh D. A life course approach to healthy aging, frailty, and capability. J Gerontol A Biol Sci Med Sci 2007; 62:717-721. (Pubitemid 350143601)
37. Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56:M158-M166. (Pubitemid 32187142)
38. Roubenoff R, Harris TB. Failure to thrive, sarcopenia and functional decline in the elderly. Clin Geriatr Med 1997; 13:613-622. (Pubitemid 28006828)
39. Semba RD, Margolick JB, Leng S, Walston J, Ricks MO, Fried LP. T cell subsets and mortality in older community-dwelling women. Exp Gerontol 2005; 40:81-87. (Pubitemid 40138749)
40. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162:2333-2341. (Pubitemid 35332516)
41. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62:1279-1286. (Pubitemid 350287617)
42. Desquilbet L, Margolick JB, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009; 50:299-306.
43. Pickering G. Frail elderly, nutritional status and drugs [review]. Arch Gerontol Geriatr 2004; 38:174-180. (Pubitemid 38096309)
44. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351:2870-2874.
45. Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005; 3:209-214. (Pubitemid 40806713)
46. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294:716-724. (Pubitemid 41159291)
47. Sigel K, Dubrow R, Silverberg M, Crothers K, Braithwaite RS, Justice AC. Cancer Screening in Patients Infected with HIV. Curr HIV AIDS Rep 2011; 8:142-152.
48. Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care 2009; 47:610-617.
49. Redelmeirer DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998; 338:1516-1520. (Pubitemid 28226280)
50. Eddy DM, Adler J, Patterson B, Lucas D, Smith KA, Morris M. Individualized guidelines: the potential for increasing quality and reducing costs. Ann Intern Med 2011; 154:627-634.
51. Fried TR, Tinetti ME, Iannone L, O'Leary JR, Towle V, Van Ness PH. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med 2011; 171:1854-1856.
52. Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 2010; 11:85.
53. Hayward RA, Kent DM, Vijan S, Hofer TP. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol 2006; 6:18.
54. Kent DM, Hayward R. Treating unrelated disorders in patients with chronic disease. N Engl J Med 1998; 339:926-928. (Pubitemid 28446860)
55. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 2009; 49:1570-1578.
56. Hogg RS, Heath KV, Yip B, Craib KJP, O'Shaughnessy MV, Schechter MT. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998; 279:450-454. (Pubitemid 28082255)
57. May MT, Ingle SM. Life expectancy of HIV-positive adults: a review. Sex Health 2011; 8:526-533.
58. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA 2012; 307:182-192.
59. Tate JP, Justice AC, for the VACS Project Team. Change in a prognostic index for survival in HIV infection after one year on cARTby level of adherence [abstract]. In: Proceedings of the 48th Annual Meeting of the Infectious Disease Society of America; October 2010; Vancouver.
60. Tate JP, Hughes MD, Justice AC, for the VACS Project Team. Do risk factors for mortality change with time on antiretroviral therapy? [abstract]. In: Proceedings of the 48th Annual Meeting of the Infectious Disease Society of America; October 2010; Vancouver.
61. Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Lampe F, Bucher HC, Sterling TR, Crane HM, Kitahata M, May MT, Sterne JAC. Performance of the refined VACS Risk Index during the first 12 months of antiretroviral therapy among US and European subjects [abstract]. In: Proceedings of the 15th International Workshop on HIV Observational Databases; 2011; Athens, Spain. P.13.
62. Akgun KM, Pisani MA, Fried TR, Butt AA, Gibert CL, McGinnis K, Huang L, Rimland D, Justice AC, Rodriguez-Barradas MC, Crothers K. Risk factors for medical intensive care unit admission in HIV infected veterans [abstract]. American Thoracic Society; 2010; New Orleans.
63. Erlandson KM, Allshouse AA, Jankowski C. Prospective comparison of three functional assessments with the Veteran's Aging Cohort Study index in virologically suppressed HIVinfected adults [abstract]. In: Proceedings of the 2nd International Workshop on HIV and Aging; 2011; Baltimore.
64. Kirkwood K, Kyriakides K, Brown S, Justice AC, Holodniy M, Tate J, Goulet J. The VACS Risk Index is highly correlated with and predictive of mortality events in the OPTIMA Study [abstract]. Joint Statistical Meetings (JSM): 2011; Miami, FL, USA.
65. Justice AC, Freiberg MS, Tracy R, Tate J, Goetz M, Butt AA, et al., VACS Project Team. Does an Index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis 2012; 54:984-994.
66. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172. (Pubitemid 351193639)
67. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006; 113:2335-2362. (Pubitemid 43947980)
68. Cook NR. Comments on 'Evaluating the added predictive ability of a newmarker: Fromarea under theROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (doi: 10.1002/sim.2929). Stat Med 2008; 27:191-195.
69. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-935. (Pubitemid 46294733)
70. Lappe JM, Horne BD, Shah SH, May HT, Muhlestein JB, Lappe DL, et al. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta 2011; 412:2094-2099.
71. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-1580. (Pubitemid 44780738)
72. Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, et al. Association betweenweight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka,Zambia. JAcquir ImmuneDefic Syndr2010;53:507-513.
73. Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin Infect Dis 2011; 53:952-960.
74. BeLue R, Okoror TA, Iwelunmor J, Taylor KD, Degboe AN, Agyemang C, et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Global Health 2009; 5:10.
75. Spencer J, Phillips E, Ogedegbe G. Knowledge, attitudes, beliefs, and blood pressure control in a community-based sample in Ghana. Ethn Dis 2005; 15:748-752. (Pubitemid 41645147)
76. Boyd CM, Weiss CO, Halter J, Han KC, Ershler WB, Fried LP. Framework for evaluating disease severity measures in older adults with comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62:286-295. (Pubitemid 47065726)
77. Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 2004; 291:2466-2470. (Pubitemid 38669190)
78. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285:2750-2756. (Pubitemid 32525372)
79. Braithwaite RS. Can life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease? Med Decis Making 2011; 31:582-595.
80. Braithwaite RS, Roberts MS, Chang CC, Goetz MB, Gibert CL, Rodriguez-BarradasMC, et al. Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med 2008; 148:178-185. (Pubitemid 351665505)
81. Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med 2011; 364:2478-2481.
82. Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med 2007; 167:2361-2365. (Pubitemid 350179532)
83. Yuo TH, Braithwaite RS, Chang CC. Applying the payoff time framework to carotid disease management [abstract]. In: Proceedings of the 33rd Annual Society for Medical Decision Making (SDMD); 2011; Chicago.
84. Gross CP, Soulos PR, Ross JS, Cramer LD, Guerrero C, Tinetti ME, et al. Assessing the impact of screening colonoscopy on mortality in the Medicare population. J Gen Intern Med 2011; 26:1441-1449.